LivingPhoenix Innovates with Groundbreaking Biomimetic Collagen Technology

Chengdu, China, is witnessing a significant advancement in biomimetic technology as LivingPhoenix Regenerative Technologies unveils its revolutionary “Stable Triple-Helix Biomimetic Collagen” on December 15, 2025. This breakthrough has garnered substantial attention, showcased at twelve prestigious academic conferences throughout November, spanning fields such as aesthetic medicine, regenerative medicine, and personal care. Experts in the industry have hailed this innovation as a pivotal shift in collagen research, marking the transition from traditional animal extraction and genetic recombination methods to a focus on structural design.

At the 3rd Badachu Aesthetic Medicine Industry Forum on October 31, founder Qin Xingjiong detailed the compliance-driven innovation pathway, earning commendations from attendees. The following month, he delivered a pivotal presentation titled “Aqueous Polymer-Based Stable Triple-Helix Biomimetic Collagen” at the “2025 10th Medical Collagen Industry Academic Conference,” presided over by Academician Liao Wanqing of the Chinese Academy of Engineering. Feedback from Academician Zhang Qiqing of the Chinese Academy of Medical Sciences praised the advancement as exemplary.

On November 7, during the 2025 Scientists (International) Conference in Changsha, Qin introduced a new concept termed “Structure-Driven Application.” This presentation resonated with over 3,000 global professionals and several Nobel laureates. Simultaneously, the company launched its Smartender Bouncy Bar at the CIIE Sichuan Pavilion, distributing nearly 1,000 trial kits that received enthusiastic responses from attendees, with comments like “Good! Younger!” and “This is a game-changer!” Notably, Chengdu Vice Mayor Chen Zhiyong visited the booth to express support for the innovation.

In a move toward international expansion, LivingPhoenix has been invited to become a Council Member of the Global Aesthetic Medicine and Health Organization. The team traveled to Indonesia to present the core advantages of their technology to Mr. Jeffri Ardiyanto from the Ministry of Health. They highlighted that their product is animal-free, ethical, and compliant with Islamic Halal requirements, receiving positive feedback from government officials. The delegation also met with a Presidential Special Envoy and Members of Parliament during their visit.

At the MediCosme 2025 International Injectable Aesthetic Technology Innovation Conference, Qin chaired a forum where Professor Xiao Jianxi, a PhD supervisor at Lanzhou University, summarized the evolution of collagen: “Animal-derived collagen is ancient yet modern, recombinant collagen is youthful and vibrant, while biomimetic collagen represents the future.” This statement captures the essence of LivingPhoenix’s mission to transform the industry.

Guided by its principle of “Biomimetic Collagen + ECM Reconstruction,” LivingPhoenix aspires to redefine regenerative medicine and aesthetic applications, showcasing the potential of “Created in China” to a global audience. As the company continues to innovate, it aims to establish a new standard in collagen research, combining scientific advancements with a commitment to ethical practices.